Ranibizumab ophthalmic and Spravato (84 MG Dose)
Determining the interaction of Ranibizumab ophthalmic and Spravato (84 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: esketamine
Brand name: Spravato
Synonyms: Spravato Nasal Spray, Spravato
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Sprintec
- Ranibizumab ophthalmic-Sprintec 28
- Ranibizumab ophthalmic-Spritam
- Ranibizumab ophthalmic-Sprix
- Ranibizumab ophthalmic-Sprix Nasal Spray
- Ranibizumab ophthalmic-Sprycel
- Spravato (84 MG Dose)-Ranitidine
- Spravato (84 MG Dose)-Ranitidine Capsule
- Spravato (84 MG Dose)-Ranitidine Hydrochloride
- Spravato (84 MG Dose)-Ranitidine Injection
- Spravato (84 MG Dose)-Ranitidine Suspension
- Spravato (84 MG Dose)-Ranitidine Syrup